دورية أكاديمية
Androgens, cardiovascular disease and osteoporosis.
| العنوان: | Androgens, cardiovascular disease and osteoporosis. |
|---|---|
| المؤلفون: | Isidori AM; Department of Medical Physiopathology, La Sapienza University, Rome, Italy. andrea.isidori@uniroma1.it, Giannetta E, Pozza C, Bonifacio V, Isidori A |
| المصدر: | Journal of endocrinological investigation [J Endocrinol Invest] 2005; Vol. 28 (10 Suppl), pp. 73-9. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print Cited Medium: Print ISSN: 0391-4097 (Print) Linking ISSN: 03914097 NLM ISO Abbreviation: J Endocrinol Invest Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : Berlin : Springer Original Publication: Milano, Published for the Italian Society of Endocrinology by Editrice Kurtis. |
| مواضيع طبية MeSH: | Aging*/blood, Androgens/*physiology , Cardiovascular Diseases/*epidemiology , Cardiovascular Diseases/*physiopathology , Osteoporosis/*epidemiology , Osteoporosis/*physiopathology, Aged ; Aged, 80 and over ; Androgens/blood ; Androgens/deficiency ; Atherosclerosis/epidemiology ; Atherosclerosis/etiology ; Atherosclerosis/physiopathology ; Body Composition/drug effects ; Body Composition/physiology ; Bone Density/drug effects ; Bone Density Conservation Agents/therapeutic use ; Bone and Bones/drug effects ; Bone and Bones/metabolism ; Cardiovascular Diseases/drug therapy ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Hormone Replacement Therapy ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Inflammation/etiology ; Inflammation/pathology ; Inflammation/physiopathology ; Male ; Middle Aged ; Osteoporosis/drug therapy ; Risk Factors ; Testosterone/blood ; Testosterone/pharmacology ; Testosterone/therapeutic use |
| مستخلص: | Epidemiological studies correlated the age-related decline of serum testosterone levels to the concomitant increase of cardiovascular diseases, osteoporosis and bone fractures. For this reason, testosterone replacement therapy (TRT) in older men with late-onset hypogonadism has been advocated. Testosterone has an anti-resorptive effect that may increase bone density at lumbar spine. Androgens may also have cardio-protective effects by improving endothelial function and reducing the risk factors for atherosclerosis. It has been proposed that atherosclerosis and osteoporosis share common pathophysiological mechanisms. The role of inflammatory cells, citokynes and calcium deposition into the vascular walls has been reviewed to explore the causal nexus between these frequently associated diseases. Experimental studies indicate that a deregulation in the commitment of pluripotent mesenchimal stem cells toward specialized phenotypes might participate in the development of these conditions. The crossed-over beneficial effect of bisphosphonate on the cardiovascular system and statins on bone metabolism supports the research for a unitary pharmacological approach to both conditions. The findings that androgens regulate mesenchimal cell differentiation, as well as body composition, lipid profile and bone metabolism, have claimed a role for TRT in aging men with late onset-hypogonadism. |
| Number of References: | 66 |
| المشرفين على المادة: | 0 (Androgens) 0 (Bone Density Conservation Agents) 0 (Diphosphonates) 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) 3XMK78S47O (Testosterone) |
| تواريخ الأحداث: | Date Created: 20060323 Date Completed: 20060421 Latest Revision: 20131121 |
| رمز التحديث: | 20240829 |
| PMID: | 16550728 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 0391-4097 |
|---|